Teladoc Health Inc.

NYSE: TDOC · Real-Time Price · USD
7.50
0.20 (2.74%)
At close: Aug 15, 2025, 12:42 PM

Teladoc Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-1B -220.37M -13.66B -428.79M
Depreciation & Amortization
382.84M 351.32M 270.64M 219.62M
Stock-Based Compensation
145.95M 201.55M 217.85M 302.59M
Other Working Capital
-15.83M 1.99M -16.01M -14.51M
Other Non-Cash Items
767.28M 7.78M 13.43B 109.1M
Deferred Income Tax
-1.15M -1.9M -7.84M 41.8M
Change in Working Capital
n/a 11.64M -60.97M -50.32M
Operating Cash Flow
293.68M 350.02M 189.29M 193.99M
Capital Expenditures
-10.79M -156.35M -172.76M -63.93M
Cash Acquisitions
n/a n/a n/a -78.66M
Purchase of Investments
n/a n/a n/a 63.93M
Sales Maturities Of Investments
n/a n/a 2.51M 60.9M
Other Investing Acitivies
-113.26M 1K 2.51M -55.22M
Investing Cash Flow
-124.05M -156.35M -167.74M -72.98M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a -278K n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.31M 10.85M 6.5M 40.95M
Financial Cash Flow
8.31M 10.85M 6.5M 40.95M
Net Cash Flow
174.65M 205.49M 24.7M 160.16M
Free Cash Flow
282.89M 193.67M 16.53M 130.06M